Microneedle arrays (MNAs) are small patches containing hundreds of short projections that
deliver signals directly to dermal layers without causing pain. These technologies are of …

Microneedles are a well-known transdermal or transdermal drug delivery system. Different
from intramuscular injection, intravenous injection, etc., the microneedle delivery system …

Nanomaterials offer unique opportunities to engineer immunomodulatory activity. In this
work, we report the Toll-like receptor agonist activity of a nanoscale adjuvant zeolitic …

Background Radiation-induced lung injury (RILI) is a prevalent complication of thoracic
radiotherapy in cancer patients. A comprehensive understanding of the underlying …

Dendritic cell vaccine (DCV) holds great potential in tumor immunotherapy owing to its
potent ability in eliciting tumor‐specific immune responses. Aiming at engineering enhanced …

To address challenges encountered by conventional drug delivery systems (DDS) such as
easy degradation, poor utilization, and low loading rates, researchers have been …

Melanoma, recognized as the most aggressive type of skin cancer, has experienced a
notable increase in cases, especially within populations with fair skin. This highly aggressive …

Microneedle arrays (MNAs) are patches displaying hundreds of micron-scale needles that
can penetrate skin. As a result, these arrays efficiently and painlessly access this immune …

Immunomodulation is a powerful therapeutic approach that harnesses the body's own
immune system and reprograms it to treat diseases, such as cancer. Innate immunity is key …

Autoimmune diseases are broadly characterized as a failure in immune tolerance. In
multiple sclerosis (MS), autoreactive immune cells attack the protective myelin sheath lining …